Advantech Capital
Asia, Hong Kong Island, Hong Kong, Central'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
Description
Advantech Capital is a private equity fund, focused on innovation-driven growth capital in China.
Investor Profile
Advantech Capital has backed more than 19 startups, with 0 new investments in the last 12 months alone. The firm has led 9 rounds, about 47% of its total and boasts 11 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series C rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Biotechnology, Pharmaceutical, Medical.
Stage Focus
- Series B (47%)
- Series A (21%)
- Series C (11%)
- Series E (5%)
- Series D (5%)
- Post Ipo Equity (5%)
- Series Unknown (5%)
Country Focus
- China (63%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- United States (37%)
Industry Focus
- Biotechnology
- Pharmaceutical
- Medical
- Augmented Reality
- Consumer Electronics
- Health Care
- Computer
- Biopharma
- Artificial Intelligence (Ai)
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
